A Phase 2b, Randomized, Double-Mask, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects with Active, Moderate to Severe Thyroid Eye Disease (TED)
100 项与 Vasaragen, Inc. 相关的临床结果
0 项与 Vasaragen, Inc. 相关的专利(医药)
100 项与 Vasaragen, Inc. 相关的药物交易
100 项与 Vasaragen, Inc. 相关的转化医学